An AI Scientist Proposed an ADHD Treatment on the Blockchain: BIO Price Surges
Key Takeaways:
- Bio Protocol’s crypto has soared 90% following a $6.9M funding boost for its AI-native platform, Bio V2.
- The funding was led by Maelstrom Fund and aims to facilitate onchain fundraising and autonomous AI co-scientists.
- Bio Protocol’s scientific proposal for an ADHD treatment targeting orexin receptors drove excitement in crypto-science circles.
- BIO’s recent price spike of 40% from a low-liquidity range highlights volatility in DeSci investments.
- LiquidChain is developing cross-chain infrastructure to support emerging DeSci and DeFi applications.
WEEX Crypto News, 2026-04-17 07:14:58
Decentralized Science and BIO Crypto’s Surge
Bio Protocol crypto recently experienced a staggering 90% price increase, catalyzed by substantial funding advancements and innovative AI applications. With a $6.9 million financial injection from Maelstrom Fund, Bio V2—a full-stack AI-native platform—was positioned at the forefront, promising onchain fundraising capabilities and AI-driven co-scientists, known as BioAgents. This development is a significant step forward in decentralized science (DeSci), capturing the focus of traders and scientists alike.
The spotlight shone further as Bio Protocol’s scientific team proposed a peptide targeting ADHD, sparking interest across crypto-science communities. Studies have shown that ADHD patients have lower levels of orexin-A/B, key in regulating arousal and attention. While existing treatments suppress orexin activity, Bio Protocol and @peptai_ have developed a peptide labeled OX2R-004, aiming to activate the OX2R receptor—potentially redefining ADHD treatment.
Can Bio Protocol Maintain Its Bullish Momentum?
Bio Protocol’s bold 40% price surge emerged from a low-liquidity environment, typifying DeSci’s high volatility. This sudden leap, while exciting, lacked a firm technical foundation, leading to questions about whether the spike can be sustained or will retract. Such moves are often followed by a period of consolidation or a partial pullback, determined by the balance between hype-driven interests and tangible utility.
Currently, BIO finds itself at an intersection between heightened interest and practical utility. To ensure a lasting price escalation, demand must translate into real-world usage, sustaining momentum as the narrative surpasses mere speculation. However, if Bio V2 fails to deliver measurable impact, the price may revert to its pre-announcement level. The broader crypto market also plays a role; downward trends in related tokens could influence BIO, potentially triggering a broader decline.
The Role of LiquidChain in DeSci’s Growth
LiquidChain has emerged as a potential game-changer in bridging the gap between decentralized science and decentralized finance applications. It’s constructing a Layer 3 protocol that combines Bitcoin’s financial strength, Ethereum’s DeFi capabilities, and Solana’s execution speed into a single, cohesive liquidity environment, without the need for asset wrapping. This innovation is key to supporting multi-chain DeSci initiatives.
LiquidChain’s architecture enables developers to create applications once and tap into user bases across multiple ecosystems—an attractive proposition for DeSci and DeFi projects. As of now, $674,947.04 has been raised in its presale, with tokens priced at $0.0145. However, presales harbor risks; success hinges on broader adoption rates, while premature entries have diminishing returns once catalysts are publicly realized.
FAQ Section
What caused Bio Protocol’s price to surge by 90%?
Bio Protocol’s price increased due to a $6.9 million funding round for its AI-native platform, Bio V2, backed by Maelstrom Fund. This elevated efforts for onchain fundraising and the involvement of AI co-scientists, attracting significant interest.
Is Bio Protocol’s ADHD treatment scientifically promising?
Bio Protocol’s ADHD treatment focuses on activating the OX2R receptor with a peptide, OX2R-004. This contrasts current treatments which suppress orexin activity, offering a scientifically provocative approach to ADHD.
Can Bio Protocol sustain its current price level?
To maintain its price, Bio Protocol needs continuous demand linked to practical usage and proven utility of its platform. Hype alone can cause the price to revert once interest wanes.
What does LiquidChain offer to DeSci and DeFi projects?
LiquidChain facilitates a unified liquidity environment across blockchain ecosystems—Bitcoin, Ethereum, and Solana—thereby supporting DeSci and DeFi applications through its deploy-once framework without asset wrapping.
Are there risks associated with investing in LiquidChain’s presale?
LiquidChain’s presale carries risks, particularly due to adoption uncertainties. The potential for low initial market listings and reliance on sustained infrastructure integration poses investment challenges.
You may also like
Former ByteDance employee's account: How I started with two Pinduoduo hard drives and made six times the profit with Seagate to achieve financial freedom?
MiCA reshuffle begins, Binance temporarily bids farewell to the EU
How does Gate redo "buying and selling stocks" from the cryptocurrency world to the stock market?
Visa and Mastercard join 140 giants to launch a new stablecoin, but the impact on the market landscape may still be limited
Circle CEO responds to OUSD's challenge: Stablecoins are a winner-takes-all business, and we will not slow down
Argentina vs Cape Verde: When a Record-Breaking Legend Meets an Unbreakable Underdog
WEEX exclusive pre-match analysis of Argentina vs Cape Verde, exploring Messi-led Argentina’s dominance and Cape Verde’s historic defensive breakout, with a breakdown of volatility, structure, and match dynamics.
WEEX Launches Depth Chart for Spot Trading
Raising interest rates to protect STRC and selling coins to maintain credit, this time the strategy has chosen the two most expensive paths
Morning Report | Samsung announces a 265.5 trillion won investment plan, focusing on semiconductor and AI computing power data centers; Vitalik publishes an article detailing the entire technology tree behind the confusion protocol (iO) mainline
In the era of AI, what is left of Bitcoin?
NeoSoul announced plans to integrate with the OKX Agentic Wallet, promoting AI agents' participation in the on-chain economy
Why Is Bitcoin Lagging Stocks in 2026? AI Stocks, ETF Outflows, and the Nasdaq Rally Explained
What you bought on CEX is really not US stocks: Analyzing the 94% liquidation monopoly and the evaporation of equity under a five-layer pipeline
In such a crowded cross-border payment arena, where is the next stop for the future?
Why Is Bitcoin Down in 2026? What We Can Learn From 2022
The large models in the United States are moving towards closure in the name of security
From the white-haired stock god to the billionaire fund mogul, the smart people shorting Nvidia are all getting rich using the same framework
Morning Report | CoinEx becomes a key hub for Iran to evade sanctions, involving over $3.8 billion in funds; Kalshi seeks a new round of financing, with a valuation potentially rising to $40 billion
Former ByteDance employee's account: How I started with two Pinduoduo hard drives and made six times the profit with Seagate to achieve financial freedom?
MiCA reshuffle begins, Binance temporarily bids farewell to the EU
How does Gate redo "buying and selling stocks" from the cryptocurrency world to the stock market?
Visa and Mastercard join 140 giants to launch a new stablecoin, but the impact on the market landscape may still be limited
Circle CEO responds to OUSD's challenge: Stablecoins are a winner-takes-all business, and we will not slow down
Argentina vs Cape Verde: When a Record-Breaking Legend Meets an Unbreakable Underdog
WEEX exclusive pre-match analysis of Argentina vs Cape Verde, exploring Messi-led Argentina’s dominance and Cape Verde’s historic defensive breakout, with a breakdown of volatility, structure, and match dynamics.

